Eli Lilly vs. Novo Nordisk: Which Weight Loss Stock is The Better Opportunity Over The Next 10 Years?
The case for Novo Nordisk. Right now Novo Nordisk has a considerable lead on Lilly in GLP-1 market share, and a couple of ...
Should Eli Lilly Investors Worry About This Unexpected FDA Move?
Eli Lilly (NYSE: LLY) sells treatments for a wide variety of therapeutic areas, but one portfolio in particular has driven ...
UK's weight loss jab Mounjaro might help people get back to work: All about it
The UK government starts a trial offering weight loss drug Mounjaro to unemployed obese individuals to improve health and ...
ConsumerAffairs7h
Compounding pharmacies can keep making Mounjaro and Zepbound copies
The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...
UK Government looks at giving unemployed people weight-loss jabs to get them back to work
Unemployed people living with obesity in the UK could receive weight-loss jabs to help get them back into work.
STAT17h
Pharmalittle: We’re reading about using Lilly obesity drug to reduce sick days, Sanofi workers striking, and more
The U.K. will study whether Lilly's weight loss drug can get people back to work and help tackle long-term sickness ...
hrgrapevine.com21h
Worker Health | UK to study use of weight loss drugs to get people back in work
The UK Government is considering using weight-loss drugs to help support obese people in returning to work and reduce the high rates of long-term sickness, which have become a significant strain on ...
Obesity not an issue for job-seekers, say charities
Adam Green, chief executive of unemployment charity Yes Manchester, said obesity was low on the list of reasons why some ...
Hope for better digestive disease care
Severe malnutrition is treated with ready-to-use therapeutic food, a paste combining peanuts, sugar, milk powder, oil, ...